UL Solutions Inc. (ULS) exhibits 49.5% gross margins and 28.3% return on invested capital within Health Care (Precision Instruments), balanced against a 22.4x enterprise multiple and 7.2% implied options volatility.
Sustained 49.5% gross profitability converts into 17.1% operating margin and 28.3% ROIC, outpacing sector cost of capital.
ROIC: 28.3% // GM: 49.5%YoY revenue trajectory of +6.4% paired with 2.65% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +6.4% // FCF YLD: 2.65%Altman Z-Score of 7.58 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 7.58 // F-SCORE: 8/9Trading at 46.9x trailing P/E (43.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 46.9x // EV/EBITDA: 22.4xOptions market prices a ±7.2% implied move with a 0.56 put/call ratio around $74.00 max pain.
IMPL MOVE: ±7.2% // P/C: 0.56Elevated industry capital intensity and customer concentration in Precision Instruments require continuous execution to defend 10.6% net margins.
NET MARGIN: 10.6% // D/E: 0.39x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ULS & activate live FRED threshold breach alerts.